Mabpharm Limited

SEHK:2181 株式レポート

時価総額:HK$1.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Mabpharm マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Hao Wang

最高経営責任者

CN¥5.6m

報酬総額

CEO給与比率19.1%
CEO在任期間5.9yrs
CEOの所有権n/a
経営陣の平均在職期間5.9yrs
取締役会の平均在任期間5.9yrs

経営陣の近況

Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

Jun 14
Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

Recent updates

Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

Jun 14
Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

More Unpleasant Surprises Could Be In Store For Mabpharm Limited's (HKG:2181) Shares After Tumbling 41%

Jan 24
More Unpleasant Surprises Could Be In Store For Mabpharm Limited's (HKG:2181) Shares After Tumbling 41%

Mabpharm (HKG:2181) Is Making Moderate Use Of Debt

Oct 20
Mabpharm (HKG:2181) Is Making Moderate Use Of Debt

Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Jan 18
Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Oct 07
Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Here's Why We're Not Too Worried About Mabpharm's (HKG:2181) Cash Burn Situation

Apr 28
Here's Why We're Not Too Worried About Mabpharm's (HKG:2181) Cash Burn Situation

Did You Miss Mabpharm's (HKG:2181) 14% Share Price Gain?

Mar 03
Did You Miss Mabpharm's (HKG:2181) 14% Share Price Gain?

We're Not Very Worried About Mabpharm's (HKG:2181) Cash Burn Rate

Jan 27
We're Not Very Worried About Mabpharm's (HKG:2181) Cash Burn Rate

Do Insiders Own Lots Of Shares In Mabpharm Limited (HKG:2181)?

Dec 09
Do Insiders Own Lots Of Shares In Mabpharm Limited (HKG:2181)?

CEO報酬分析

Mabpharm の収益と比較して、Hao Wang の報酬はどのように変化したか?
日付総報酬給与会社業績
Dec 31 2023CN¥6mCN¥1m

-CN¥209m

Sep 30 2023n/an/a

-CN¥202m

Jun 30 2023n/an/a

-CN¥194m

Mar 31 2023n/an/a

-CN¥202m

Dec 31 2022CN¥3mCN¥1m

-CN¥211m

Sep 30 2022n/an/a

-CN¥237m

Jun 30 2022n/an/a

-CN¥263m

Mar 31 2022n/an/a

-CN¥278m

Dec 31 2021CN¥5mCN¥1m

-CN¥292m

報酬と市場: Haoの 総報酬 ($USD 771.78K ) は、 Hong Kong市場 ($USD 359.13K ) の同規模の企業の平均を上回っています。

報酬と収益: Haoの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Hao Wang (55 yo)

5.9yrs

在職期間

CN¥5,596,000

報酬

Dr. Hao Wang serves as Chief Executive Officer and Executive Director at Mabpharm Limited since October 28, 2020 and July 20, 2018 respectively and also serves as Chief Scientist since August 2018. Dr. Wan...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Hao Wang
Chief Scientist5.9yrsCN¥5.60mデータなし
Yunfeng Li
CFO, Joint Company Secretary & Executive Director5.9yrsCN¥1.58mデータなし
Jing Tao
VP & Executive Directorno dataCN¥1.54mデータなし
Sheng Hou
VP & Executive Directorless than a yearCN¥70.00kデータなし
Jing Li
Vice President5.9yrsCN¥1.40mデータなし
Ho Yin Tsang
Joint Company Secretaryno dataデータなしデータなし

5.9yrs

平均在職期間

48.5yo

平均年齢

経験豊富な経営陣: 2181の経営陣は経験豊富で経験豊富です(平均在職期間は5.8年)。


取締役

名称ポジション在職期間報酬所有権
Hao Wang
Chief Scientist6yrsCN¥5.60mデータなし
Yunfeng Li
CFO, Joint Company Secretary & Executive Director6yrsCN¥1.58mデータなし
Jing Tao
VP & Executive Director3.8yrsCN¥1.54mデータなし
Sheng Hou
VP & Executive Directorless than a yearCN¥70.00kデータなし
Shuge Jiao
Non-Executive Chairman6yrsデータなしデータなし
Liangzhong Guo
Independent Non-Executive Director5.9yrsCN¥108.00kデータなし
Yanyun Zhang
Independent Non-Executive Director5.9yrsCN¥108.00kデータなし
Louis Ho Ming
Independent Non-Executive Director2.1yrsCN¥108.00kデータなし
Weizhu Qian
Non-Executive Directorless than a yearCN¥445.00kデータなし

5.9yrs

平均在職期間

51yo

平均年齢

経験豊富なボード: 2181の 取締役会経験豊富 であると考えられます ( 5.8年の平均在任期間)。